How has been the historical performance of Anuh Pharma?

Answer:The historical performance of Anuh Pharma shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Anuh Pharma's net sales increased from INR 486.65 crore in March 2022 to INR 661.51 crore in March 2025, reflecting a steady upward trend. The total operating income followed a similar pattern, rising from INR 486.65 crore in March 2022 to INR 661.51 crore in March 2025. However, the total expenditure also grew, from INR 439.80 crore in March 2022 to INR 600.61 crore in March 2025, impacting the operating profit, which decreased from INR 75.14 crore in March 2024 to INR 60.90 crore in March 2025. Profit before tax showed a decline from INR 78.31 crore in March 2024 to INR 61.01 crore in March 2025, while profit after tax also fell from INR 60.06 crore to INR 47.35 crore in the same period. The company's total assets increased from INR 347.17 crore in March 2022 to INR 504.55 crore in March 2025, indicating growth in the balance sheet. Cash flow from operating activities improved significantly from INR 12 crore in March 2024 to INR 37 crore in March 2025, contributing to a net cash inflow of INR 12 crore by the end of March 2025. Overall, while Anuh Pharma has shown growth in sales and assets, profitability metrics have faced some challenges in recent years.